Abstract:DNA damage may regulate microRNA (miRNA) biosynthesis at the levels of miRNA transcription, processing and maturation. Although involvement of E2F1 in the regulation of miRNA gene activation in response to DNA damage has been documented, little is known about the role of E2F1 in miRNA processing. In this study we demonstrate that E2F1 enhances miR-630 biosynthesis under cisplatin (CIS) exposure through promoting DROSHA-mediated pri-miR-630 processing. Northern blot and RT-qPCR revealed that CIS exposure caused not only an increase in pri-miR-630 but also much more increase in pre-miR-630 and mature miR-630. The increases in pri-miR-630 and pre-miR-630 expression in unmatched proportion indicated that primary transcript processing was involved in CIS-stimulated miR-630 biosynthesis. Furthermore, combination of reporter enzyme assay with mutation and over-expression of E2F1 showed that induction of DROSHA promoted miR-630 expression, in which CIS-induced E2F1 activated DROSHA gene expression by recognizing and binding two E2F1 sites at the positions -214/-207 and -167/-160 of the DROSHA promoter. The increased binding of E2F1 to the DROSHA promoter in CIS-exposed cells was further evidenced by chromatin immunoprecipitation assay. Together, E2F1-regulated DROSHA promotes pri-miR-630 processing, thereby, contributes to CIS-stimulated miR-630 expression. The involvement of E2F1-dependent DROSHA activation in pri-miRNA processing under DNA damage stress will provide further insight into the regulation of miRNA biosynthesis. These data also give us a deeper understanding of E2F1 role in response to DNA damage.

eIF3a regulation of mTOR signaling and translational control via HuR in cellular response to DNA damage

eIF3a Regulation of NHEJ Repair Protein Synthesis and Cellular Response to Ionizing Radiation

Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma

Effect of Eif3a on Response of Lung Cancer Patients to Platinum-Based Chemotherapy by Regulating Dna Repair

Translational Regulator Eif2α in Tumor

mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3 IBTK -mediated ubiquitination of eIF4A1 in cancer cells

The Mtor–s6k Pathway Links Growth Signalling to DNA Damage Response by Targeting RNF168

mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3 -mediated non-degradative ubiquitination of eIF4A1

eIF3i regulation of protein synthesis, cell proliferation, cell cycle progression, and tumorigenesis

Translational Regulation of RPA2 Via Internal Ribosomal Entry Site and by Eif3a

Mtorc1/s6k1 Signaling Promotes Sustained Oncogenic Translation Through Modulating CRL3IBTK-mediated Non-Degradative Ubiquitination of Eif4a1

eIF3 mRNA selectivity profiling reveals eIF3k as a cancer-relevant regulator of ribosome content

Translation initiation factor eIF3a regulates glucose metabolism and cell proliferation via promoting small GTPase Rheb synthesis and AMPK activation

eIF3i promotes colorectal cancer cell survival via augmenting PHGDH translation

Eif3 Regulation of Protein Synthesis, Tumorigenesis, and Therapeutic Response.

eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27 Kip1 translation

MicroRNA-191 Modulates Cisplatin-Induced DNA Damage Response by Targeting RCC2.

USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response

Eukaryotic Translation Initiation Factor 3 and Tumor

E2f1-Regulated Drosha Promotes Mir-630 Biosynthesis in Cisplatin-Exposed Cancer Cells

eIF3i activity is critical for endothelial cells in tumor induced angiogenesis through regulating VEGFR and ERK translation.